Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease

Overview of attention for article published in The Journal of Prevention of Alzheimer's Disease, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 22 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease.

Alzforum, 06 Apr 2018

. Minimizing the Sample Sizes of Clinical Trials on Preclinical and Early Symptomatic Stage of Alzheimer Disease.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.